Third Pole Therapeutics Secures $15 Million Debt Facility with Avenue Venture Opportunities Fund, L.P.

Funding to Support Validation Testing of the First Tankless Inhaled Nitric Oxide (iNO) Wearable Device for Home Use WALTHAM, Mass., April 15, 2021 -- (Healthcare Sales & Marketing Network) -- Third Pole Therapeutics, a privately held company developing... Devices, Venture Capital Third Pole Therapeutics, inhaled nitric oxide, tankless iNO
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news